Connect the episode to operating events
Record when foam appears, its persistence and location, and whether it follows a discharge, production change or industrial CIP event. Add flow, pH, temperature, dissolved oxygen, MLSS and TMP. Keep photographs and representative feed and mixed-liquor samples.
Temporary white foam and persistent biomass-rich foam need not have the same origin. Appearance guides sampling but cannot identify an organism or chemical. Inspect pumps, air ingress and return flows that may generate foam or carry it towards the membrane compartment.
Measure compounds relevant to the process
Select surfactant methods appropriate to the formulations used on site. Anionic, non-ionic and other groups are not necessarily represented by one generic concentration. Distinguish fats, COD and cleaning chemicals. Reduced COD does not demonstrate that all foam-forming substances have disappeared from the water.
Review the dates of changes in detergents, disinfectants and process additives. Request composition and technical information where required for compatibility assessment. Published research links biological foam with changes in membrane fouling, but it does not provide a universal dosing instruction for a different industrial water matrix.
Test antifoam against the membrane duty
Obtain approval for the exact commercial formulation and exposure rather than simply a category such as silicone. A beaker test may demonstrate foam collapse without revealing membrane fouling. Compare filterability and subsequent recovery with an untreated control using the same process water and test conditions.
Record active dose, accumulation in recirculation and the response across repeated cycles. Research on antifoams demonstrates formulation- and membrane-dependent effects; its laboratory flux figures cannot be presented as Neptuno MBR performance. Assess oxygen transfer, biology and downstream treatment before choosing continuous dosing.
Resolve the cause and agree acceptance
For campaign-dependent feed, consider segregation and equalisation with the plant engineering team. For a biological cause, review the process with its responsible operator rather than changing sludge age or aeration without evidence. Membrane separation does not replace management of an inhibitory incoming load.
Define success through stable operation: controlled foam, compliant quality and known permeability and consumption. Include level alarms, overflow prevention and residual management. To assess an external retrofit, provide the event record together with the recirculation drawing and the proposed module’s operating limits.
Common questions
Is every antifoam compatible with UF?
No. It may control foam while fouling membranes or affecting downstream treatment. Check and test the exact product.
Will increasing air always remove foam?
No. It may generate more foam and consume additional energy. The response depends on the cause, biology and membrane operating requirements.
Sources and documentation
- Membrane fouling caused by biological foams in a submerged membrane bioreactor: Mechanism insights, Water Research, 2020
- Fouling of microfiltration membranes by broth-free antifoam agents, Biotechnology and Bioengineering, 1997
- US EPA — Wastewater Management Fact Sheet: Membrane Bioreactors
- DuPont — Inge TR Rack Modules and Modules for Open Platform, Process and Design Manual, Rev 9, April 2026